Federal News
Congress Advances Infant Formula Safety Legislation
March 11, 2026
Congresswoman Rosa DeLauro has introduced the bipartisan Infant Formula Safety Modernization Act to strengthen federal oversight and safety standards for infant formula manufacturing in the United States. This legislation mandates expanded pathogen testing, enhanced environmental monitoring, and increased FDA and Congressional oversight to prevent contamination outbreaks like those recently experienced at Abbott Nutritionโs Sturgis, Michigan facility. Procurement professionals and contractors involved in infant formula production, testing, and regulatory compliance should anticipate evolving federal requirements that may impact contract specifications, quality assurance protocols, and supplier qualifications.
- Why this matters: The Act signals heightened federal scrutiny and stricter safety mandates for infant formula manufacturers, potentially affecting procurement criteria and contract compliance.
- Agencies and contractors should prepare for increased testing and monitoring obligations that could require updated capabilities or certifications.
- This development may lead to new contracting opportunities for firms specializing in food safety testing, environmental monitoring technologies, and regulatory consulting.
- Organizations should evaluate current supply chain and quality control processes to align with anticipated regulatory enhancements and avoid disruptions.
Multiple crises year after year make clear that the current system is not working. My Infant Formula Safety Modernization Act closes critical gaps to prevent the next outbreak before it occurs.
— Congresswoman Rosa DeLauro
Agencies
Food and Drug Administration, U.S. Congress